scorecardresearch
Follow Us:
Monday, September 28, 2020

AstraZeneca

ASTRAZENECA NEWS

AstraZeneca gets partial immunity in low-cost EU vaccine deal

September 25, 2020 2:38 pm

AstraZeneca has secured the European Union's backing in a confidential agreement which reflects the lower price sought by the British drugmaker, the official said.

Mumbai: KEM to start screening participants for vaccine trial from today

September 23, 2020 11:56 am

The vaccine trial had been halted globally after a participant reported an adverse event. Following inquiry the trial was restarted. The Oxford vaccine trial will cover 1,600 participants in India across 10-12 sites.

Quixplained: When will a coronavirus vaccine be ready? A look at the progress of top Covid-19 vaccine candidates

September 27, 2020 12:49 pm

Coronavirus vaccine: The most-talked-about vaccines are being developed by AstraZeneca in partnership with Oxford University; Pfizer and BioNTech; Johnson and Johnson; Sanofi along with GlaxoSmithKline; and Novavax.

Covid-19 vaccine update, Sept 16: US to probe AstraZeneca incident; scientists seek data on Russian shot

September 22, 2020 7:42 am

Coronavirus (COVID-19) vaccine latest update, September 16: Multiple news reports said the NIH had launched its own investigation into the incident that led to the halting of AstraZeneca vaccine trials two weeks ago.

Days after halt, AstraZeneca says UK trials for Covid-19 vaccine to resume

September 12, 2020 10:00 pm

The company said it will continue to work with health authorities “across the world” and “be guided” as to when other clinical trials can resume.

Explained: What Oxford-AstraZeneca Covid-19 vaccine trial pause means for trials

September 16, 2020 1:51 pm

Oxford-AstraZeneca Coronavirus Vaccine: Trials of Oxford-AstraZeneca’s Covid-19 vaccine have been paused, reportedly after severe adverse reaction in a participant in England. What happens to the India trials? Why do some see it as a blessing in disguise?

Now halted, AstraZeneca trials were on in India too

September 09, 2020 10:58 am

In a statement, AstraZeneca described its decision to halt trials as "routine action which has to happen whenever there is potentially unexplained illness in one of the trials".

After Moderna, Oxford vaccine triggers immune response in early tests

July 21, 2020 12:42 am

The Oxford AstraZeneca ChAdOx1 nCoV-19 vaccine candidate is currently undergoing large (Phase III) human trials in the United Kingdom and Brazil.

Pfizer walks away from AstraZeneca deal

May 27, 2014 1:41 am

Pfizer’s final offer was at a price that many analysts had previously suggested would bring AstraZeneca to the table for serious negotiations.

AstraZeneca rejects final Pfizer bid

May 20, 2014 1:04 am

Shares in AstraZeneca tumbled 13 per cent to £42 by late morning as prospects of a takeover ebbed away.